Definition of Data. The data subject to this Agreement consists of {description of data} (the “Data”).
Definition of Data. Data shall mean the data produced by DOHMH to Data Recipient pursuant to this Agreement and will include, without limitation, the specific description and data elements set forth in Attachment A to this Agreement.
Definition of Data. ESYS needs to determine the quantity and type of data to backup. Qualification Quantity of Data GB's of full data/week on all server(s) GB's of differential data/week on all server(s) # of files in a full on all server(s) # of files in a differential on all server(s) Type of Data to be backed up What method is currently used to backup any databases? Is your data confidential (dept name)
Definition of Data. For purposes of this addendum, “Data” is defined as any and all information whose collection, disclosure, protection, and disposition is governed by state or federal law or regulation, particularly information subject to the Family Educational Rights and Privacy Act (“FERPA”). This information includes, but is not limited to, student names, addresses, dates of birth, social security numbers, family information, health information, and student records, and other personally identifiable information identified by law.
Definition of Data. For the purpose of this Agreement, "data" means any information pertaining to Employer’s participation with PEHP, Plan Rates, this Agreement, PEHP or its business practices, or the personal health information (as defined by federal law) of any individual participating in the Plan administered by PEHP.
Definition of Data. The types of data covered by the clause shall include sales data (such as transaction records and COUNTY information), marketing data (such as campaign analytics and COUNTY interactions) and booking data (such as reservations and scheduling information).
Definition of Data. “Data” means all results, information and data, including clinical data, generated by or on behalf of a party under this Agreement as a result of Developing Licensed Formulations for use in the Licensed Field, including in accordance with the Initial Development Plan, any Secondary Disease Development Plan or any Supplemental Disease Development Plan (including as any of the foregoing may be amended), or in the course of obtaining or maintaining MA Approvals for Licensed Products. Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment under Rule 406 of the Securities Act of 1933, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission
